EcoDrugPlus

Ribosomal Protein L38

Ensembl ID : ENSCVAG00000020481
Gene Symbol: RPL38
1 Cross references
247 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSCVAG00000004990
Gene Symbol: RPL39
3 Cross references
405 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSCVAG00000006005
Gene Symbol: RPL4
3 Cross references
340 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSCVAG00000004913
Gene Symbol: RPL5
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L5b

Ensembl ID : ENSCVAG00000012116
Gene Symbol: RPL5B
2 Cross references
457 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSCVAG00000018272
Gene Symbol: RPL6
3 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSCVAG00000009869
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSCVAG00000015763
Gene Symbol: RPL7A
4 Cross references
372 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSCVAG00000015806
Gene Symbol: RPL8
3 Cross references
278 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSCVAG00000007241
Gene Symbol: RPL9
3 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSCVAG00000014422
Gene Symbol: RPS10
3 Cross references
384 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSCVAG00000013528
Gene Symbol: RPS11
3 Cross references
287 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).